409A Valuation at Series B and Series C: What Changes and Why It Matters

Most founders encounter their first 409A valuation at the seed stage. It is a relatively straightforward exercise: a modest capital structure, limited operating history, and a valuation anchored almost entirely by the most recent transaction price using the backsolve method. The common stock fair market value comes in at 10% to 25% of the preferred price, the appraiser applies a meaningful discount for lack of marketability, and the report is complete in a week.

By Series B and Series C, that simplicity is gone. The company has real revenue, institutional investors with complex liquidation preferences, a growing employee base that cares deeply about their strike prices, and an increasing probability of a near-term liquidity event that changes how every assumption in the model is calibrated. The 409A valuation methodology that worked at seed is no longer appropriate, and using it can produce a valuation that is either non-defensible under IRS scrutiny or materially unfair to employees.

This guide explains exactly what changes in a 409A valuation Series B and beyond, why those changes happen, and what founders and CFOs need to understand before engaging a valuation firm after their next round closes.

Why 409A Valuations Get More Complex After Series A

At the pre-seed and seed stage, a company's capital structure is typically simple. There may be one class of preferred stock, a single liquidation preference, and limited operating history to analyze. The backsolve method — which infers enterprise value from the most recent arm's-length transaction — is widely accepted and easy to apply. Appraisers rely heavily on the transaction price because there is little else to anchor the analysis.

Series A begins to shift this dynamic. By Series B, the complexity is substantially higher across every dimension of the analysis:

• Capital structure complexity: Multiple series of preferred stock with different liquidation preferences, participation rights, and anti-dilution provisions create a layered waterfall that must be modeled before common stock value can be determined.
• Operating history: The company now has 18 to 36+ months of revenue data, making income-based methods meaningful and sometimes required by auditors.
• Comparable companies: At scale, peer group analysis using public company multiples becomes more relevant and more defensible than at early stages.
• Exit visibility: The probability and timing of a liquidity event — IPO, acquisition, or secondary market transaction — becomes a real input rather than a theoretical assumption, affecting both the equity allocation model and the discount for lack of marketability.
• Audit scrutiny: Series B companies typically work with Big Four or regional CPA firms whose audit teams apply significantly more scrutiny to 409A valuations than was applied at the seed stage.

These factors compound. An appraiser performing a 409A valuation Series B engagement cannot simply repeat the backsolve analysis used after the seed round. The AICPA Practice Aid on accounting for equity-based compensation, which governs AICPA-compliant 409A work, explicitly requires that appraisers select methodologies appropriate to the company's stage, available data, and economic circumstances. Applying an oversimplified method at the growth stage is a compliance risk, not a time-saver.

How Series B Funding Changes Your 409A Valuation

Closing a Series B is a material event that immediately invalidates your existing 409A valuation. As we covered in our guide on 409A valuations after a funding round, you must obtain a new valuation before granting any stock options after the round closes, regardless of when your previous valuation was issued.

Beyond the compliance trigger, the 409A valuation Series B process changes in three fundamental ways from what you experienced at seed or Series A.

The Backsolve Method Becomes Less Dominant

At early stages, the backsolve method is often used as the sole or primary approach because there is no meaningful operating data to support other methods. At Series B, appraisers are expected to triangulate across multiple methodologies. The backsolve from the Series B transaction price remains relevant — it reflects a real arm's-length transaction with sophisticated investors — but it must be corroborated by market and income approaches.

Series B valuation methods now routinely include:

• Guideline Public Company Method (GPCM): Revenue or EBITDA multiples from comparable public companies, adjusted for size, growth rate, and risk profile relative to the subject company.
• Guideline Transaction Method (GTM): Multiples from comparable M&A transactions in the sector, providing a control premium benchmark.
• Discounted Cash Flow (DCF): A multi-year projection model discounted to present value at a risk-adjusted rate, which becomes increasingly meaningful as the company's revenue trajectory is established.

The Waterfall Analysis Grows More Complex

Once enterprise value is determined, it must be allocated across the company's capital structure to arrive at the fair market value of a single common share. By Series B, the typical cap table includes Series Seed, Series A, and Series B preferred stock — each potentially with different liquidation preferences, participation caps, and conversion ratios. The waterfall analysis models how proceeds are distributed at various exit values, and the common stock value is derived from this analysis.

This is where the expertise of the appraiser matters most. Errors in waterfall modeling — particularly around participating preferred stock and stacked liquidation preferences — produce materially incorrect common stock values that will not survive audit scrutiny. A 409A valuation Series B engagement that uses a simplified allocation model, without properly capturing each liquidation preference tier, is not suitable for IRS safe harbor purposes.

Series C and Beyond: The Shift in Valuation Methodology

By Series C, many companies have crossed critical operating thresholds that fundamentally change the valuation analysis. ARR may exceed $20 million. The path to profitability is visible. Exit scenarios — particularly IPO — are no longer theoretical. The 409A valuation Series C engagement reflects all of these changes.

Several methodological shifts are characteristic of late-stage 409A valuations:

The 409A valuation Series C process also tends to involve more documentation and more back-and-forth with the appraiser. Auditors at this stage scrutinize the assumptions underlying the DCF — particularly the projected revenue growth rate, terminal growth rate, and weighted average cost of capital (WACC) — and expect the appraiser to defend those assumptions with reference to the company's actual operating performance and sector benchmarks.

For more context on how these figures vary by stage, see our analysis of 409A valuation benchmarks by stage.

Enterprise Value Methods at the Growth Stage

Determining enterprise value is the first of two steps in any 409A valuation. The second is equity allocation, discussed in the next section. At the growth stage, enterprise value is typically derived from a weighted combination of three approaches.

Market Approach: Comparable Company Multiples

The guideline public company method applies revenue or EBITDA multiples from a peer group of publicly traded companies to the subject company's financials. At Series B and C, the company typically has sufficient revenue to make this analysis meaningful. A SaaS company raising a 409A valuation Series B at $15 million ARR, for example, might be valued using a multiple of annualized recurring revenue derived from publicly traded SaaS peers with similar growth rates and gross margins.

The appraiser applies adjustments to the public company multiples to account for the subject company's private status, smaller scale, and execution risk. These adjustments are informed by the discount for lack of marketability analysis applied later, but they also inform the enterprise value before equity allocation.

Income Approach: Discounted Cash Flow

A DCF model projects the company's free cash flows over a five- to ten-year forecast period and discounts them at the WACC. At Series B and C, this method becomes increasingly relevant because:

• Historical revenue data provides a basis for projection assumptions
• The company's unit economics (CAC, LTV, gross margin) are observable
• Comparable companies provide benchmarks for terminal growth rate and cost of capital

The WACC for a growth-stage private company typically ranges from 15% to 30%, reflecting the premium required to compensate investors for illiquidity and execution risk. This is substantially higher than public company WACCs, which is one reason why a high preferred stock price does not translate directly into high common stock value even at late stages.

Transaction-Based Methods

The backsolve from the most recent priced round remains relevant at Series B and C as a market-based anchor. However, it should be reconciled with the other methods rather than treated as the definitive answer. If the DCF and comparable company analysis imply an enterprise value significantly below what the backsolve suggests, that divergence must be explained and resolved in the report — not ignored. A well-documented late-stage 409A valuation Series B report will address these reconciliation points explicitly, because auditors will ask about them.

Equity Allocation: OPM vs. PWERM at Series B and C

Once enterprise value is determined, it must be allocated across the capital structure. The two primary methods are the Option Pricing Model (OPM) and the Probability-Weighted Expected Return Method (PWERM). The choice between them — and the assumptions underlying each — changes materially at the growth stage.

Option Pricing Model at Series B and C

The OPM treats each class of equity as a call option on the company's enterprise value, using the Black-Scholes framework to allocate value across the capital structure. Key inputs include:

• Time to exit: The expected holding period before a liquidity event. At Series B, this is often modeled at three to five years; at Series C, it may compress to two to four years.
• Volatility: The annualized volatility of the company's equity, inferred from comparable public companies. At the growth stage, volatility is typically in the 50% to 80% range for high-growth companies.
• Risk-free rate: The yield on U.S. Treasury securities with a duration matching the expected time to exit.

The OPM is well-suited for situations where exit timing and form are highly uncertain. At Series B, it often remains the primary allocation method, sometimes combined with a PWERM hybrid approach that blends OPM outputs with discrete scenario analysis.

PWERM at Series C: When Exit Scenarios Become Concrete

At Series C, the PWERM becomes more applicable because the company can define discrete exit scenarios with reasonable probability estimates. A typical PWERM applied in a 409A valuation Series C engagement might include the following scenario structure:

Note: These are illustrative scenario parameters only, not recommendations. Actual probabilities and exit assumptions must be developed by a qualified independent appraiser based on the specific company's circumstances, operating performance, and market conditions at the time of valuation.

The weighted common stock value across these scenarios is then discounted for lack of marketability to arrive at the final FMV per share. For a deeper discussion of how these frameworks affect your option strike price, see our guide on 409A valuation and stock options.

Discount for Lack of Marketability at Late-Stage Companies

The discount for lack of marketability (DLOM) reflects the fact that a holder of private company common stock cannot freely sell that stock. This discount is applied after equity allocation to convert the allocated common stock value into the fair market value of a freely tradeable share, then adjusted downward to reflect the actual illiquidity of the stock.

The DLOM compresses as a company matures and a liquidity event approaches. The directional pattern is consistent across late-stage 409A valuations:

Note: These ranges are directional benchmarks based on market practice. Actual DLOM must be determined by a qualified independent appraiser based on the specific facts and circumstances of the company being valued.

The DLOM is supported by quantitative models — most commonly the Longstaff model, the Finnerty model, and put option-based approaches — that estimate the cost of the holding period restriction implicit in private company ownership. At Series C, these models are expected to be applied with rigor and their outputs reconciled with empirical restricted stock studies. A subjectively chosen DLOM without quantitative support will not satisfy the AICPA standards required for IRS safe harbor qualification in a late-stage 409A valuation.

Common Stock as a Percentage of Preferred Price: What to Expect

One of the most common questions from growth-stage founders is: why does the 409A valuation still produce a common stock FMV that is significantly lower than what investors paid for preferred shares?

The answer is structural, not arbitrary. For a complete explanation, see our article on why 409A is lower than preferred price. The short version is that preferred stock carries economic rights — liquidation preferences, anti-dilution protection, and redemption rights — that make it intrinsically more valuable than common stock in the majority of exit scenarios. These structural advantages are not negligible at the growth stage; they are often more complex and more material than at seed stage, because the preferred stack is larger and more layered.

That said, the ratio of common stock value to preferred price does increase meaningfully as a company scales. These directional ranges reflect both the narrowing DLOM and the improved economic position of common stock as enterprise value grows above the liquidation preference threshold:

• Seed / Series A: common stock typically 15% to 35% of preferred price
• Series B: common stock typically 35% to 55% of preferred price
• Series C: common stock typically 50% to 75% of preferred price
• Pre-IPO: common stock typically 75% to 90% of preferred price

At higher exit values, the liquidation preference represents a smaller fraction of total proceeds, and common stock participates more fully in upside. This compression of the preferred-to-common discount is a direct function of the company's success — and it is one reason why later-stage option grants carry higher strike prices but still represent meaningful equity upside for employees.

How Board Composition and Governance Affect 409A at Series B+

Series B and C companies typically have formal boards with independent directors, institutional investor observers, and active audit committees. This governance structure affects the 409A valuation process in several practical ways.

Board approval and documentation: The board is responsible for approving option grants and setting strike prices. At the growth stage, boards are more likely to require formal documentation confirming that the strike price equals or exceeds the FMV determined by the most recent valid 409A valuation. This documentation requirement means that late 409A renewals or gap periods become visible and consequential — not just legal risks, but operational friction that delays equity grants for incoming employees.

Audit committee oversight: Series B and C companies preparing for a potential IPO are subject to significantly higher audit standards. The audit committee will review the 409A valuation as part of the stock-based compensation expense process. Auditors will test the assumptions underlying the valuation — the DCF projections, the peer group selection, the DLOM methodology — and may request that the appraiser document and defend specific conclusions. Valuations produced by firms without AICPA-credentialed analysts or without proper documentation standards are increasingly rejected by audit teams at this stage.

409A as a governance instrument: At the growth stage, the 409A valuation intersects with other governance processes — option pool planning, executive compensation benchmarking, and secondary tender offer pricing. CFOs at Series B and C companies increasingly use the 409A as an input into broader compensation strategy, not just a compliance checkbox. This means the quality and defensibility of the valuation matters beyond the immediate grant cycle.

Timing Your 409A Valuation Around a Series B or C Round

Timing is one of the most operationally critical aspects of the late-stage 409A valuation process. The window between round closing and the next option grant cycle is often narrow, and delays in obtaining a new valuation can freeze the company's ability to issue equity to new hires.

For companies with aggressive hiring plans after a round, it is common practice to complete the post-close 409A within two to three weeks and issue a bulk grant covering all pending recipients simultaneously, rather than granting piecemeal while the valuation is in progress. This approach is cleaner from a compliance documentation perspective and reduces the risk of grants being issued under an invalidated or incomplete valuation.